Swanson Premium Brand

Fiber Dense Glucomannan (Konjac Root) 700 mg

F
N+ Score45
Vitamins & MineralsServing: 1 Capsule(s)Type: Fiber and Other Nutrients

Swanson Premium Brand Fiber Dense Glucomannan (Konjac Root) is a fiber supplement providing 700 mg of Glucomannan per capsule. Glucomannan, derived from Konjac Root, is a soluble dietary fiber commonly used to support digestive health and may contribute to feelings of fullness. The product contains a single active ingredient, Glucomannan, at a dosage of 700 mg, though it is not specified if this amount meets clinically studied levels for specific benefits like weight management or cholesterol reduction. With an N+ Score of 45 and a grade of F, this product falls into the below-average tier, indicating potential areas for improvement in its formulation or evidence base. Consumers seeking a simple Glucomannan supplement may consider this, but should research optimal dosages for their specific goals.

About This Product

Fiber Dense Glucomannan (Konjac Root) 700 mg by Swanson Premium Brand is a vitamins & minerals supplement containing 1 active ingredients. It has earned an N+ Score of 45/100 (Grade F).

N+ Score Breakdown

Ingredient Adequacy50/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness0/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity36/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed

Weaknesses

  • −Missing several expected ingredients for its category
  • −Limited ingredient diversity compared to category norms

Ingredient Analysis (1 ingredients)

IngredientAmountDose Adequacy
Glucomannan700.000 mgN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.